University Hospitals Birmingham NHS Foundation Trust

Loading results...
View full results list

Medicines A–Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

N

Status	Drug name	NICE TAs	Comments
	Nifedipine (Unlicensed)
	Nifedipine capsules		Brand rationalisation, APC preferred brands: Adipine MR Tablets, Adipine XL Tablets, Coracten SR Capsules, Coracten XL Capsules
	Nifedipine M/R capsules		Brand rationalisation, APC preferred brands: Adipine MR Tablets, Adipine XL Tablets, Coracten SR Capsules, Coracten XL Capsules
	Nifedipine M/R tablets		Brand rationalisation, APC preferred brands: Adipine MR Tablets, Adipine XL Tablets, Coracten SR Capsules, Coracten XL Capsules
	Nilotinib capsules	TA251 - Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia TA241 - Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia (CML) (part review of NICE technology appraisal guidance 70), and dasatinib and nilotinib for people with CML for whom treatment with imatinib has failed because of intolerance
	Nimodipine infusion		Hospital use only
	Nimodipine tablets
	Nintedanib	TA379 - Nintedanib for treating idiopathic pulmonary fibrosis TA747 - Nintedanib for treating progressive fibrosing interstitial lung diseases TA864 - Nintedanib for treating idiopathic pulmonary fibrosis when forced vital capacity is above 80% predicted
	Nintedanib#8.1	TA347 - Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non-small-cell lung cancer
	Niraparib	TA528 - Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer TA673 - Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy

Building healthier lives